U.S. flag

An official website of the United States government

NM_020988.3(GNAO1):c.662C>A (p.Ala221Asp) AND Neurodevelopmental disorder with involuntary movements

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Jun 15, 2018
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000626015.4

Allele description [Variation Report for NM_020988.3(GNAO1):c.662C>A (p.Ala221Asp)]

NM_020988.3(GNAO1):c.662C>A (p.Ala221Asp)

Gene:
GNAO1:G protein subunit alpha o1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q13
Genomic location:
Preferred name:
NM_020988.3(GNAO1):c.662C>A (p.Ala221Asp)
HGVS:
  • NC_000016.10:g.56336799C>A
  • NG_042800.1:g.150461C>A
  • NM_020988.3:c.662C>AMANE SELECT
  • NM_138736.3:c.662C>A
  • NP_066268.1:p.Ala221Asp
  • NP_620073.2:p.Ala221Asp
  • NC_000016.9:g.56370711C>A
  • NM_020988.2:c.662C>A
  • p.A221D
Protein change:
A221D
Links:
dbSNP: rs1555507479
NCBI 1000 Genomes Browser:
rs1555507479
Molecular consequence:
  • NM_020988.3:c.662C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_138736.3:c.662C>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Neurodevelopmental disorder with involuntary movements (NEDIM)
Identifiers:
MONDO: MONDO:0060491; MedGen: C4479569; OMIM: 617493

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000746624Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 1, 2016)
de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000924543Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 15, 2018)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedresearch
Whitede novoyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN, SCV000746624.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1White1not providednot providedclinical testing
(GTR000553916.1)
PubMed (1)

Description

Our patient has the more recently described phenotype (MIM #617493) associated with de novo heterozygous GNAO1 mutations, which includes developmental delay and movement disorder. Our patient's presentation is milder than those cases reported in the literature to date.

Description

This variant, which is de novo in our patient, is novel (absent from 1000 Genomes, ExAC, gnomAD & Geno2MP databases), and is predicted to be damaging (SIFT, PolyPhen2, MutationTaster), and the patient's clinical presentation is similar to other reported cases. This individual has been reported in PMID: 30682224 (patient 8).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided
(GTR000553916.1)
1not providednot providednot provided

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV000924543.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)

Description

The heterozygous p.Ala221Asp variant was identified by our study, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the UDN, in one individual with neurodevelopmental disorder with involuntary movements. Trio exome analysis showed this variant to be de novo. This variant was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to definitively determine pathogenicity. In summary, although additional studies are required to fully establish its pathogenicity, this variant is likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024